Twelve-year mortality in HIV-infected patients receiving antiretroviral therapy: the role of social vulnerability. The ANRS CO8 APROCO-COPILOTE cohort

被引:7
作者
Protopopescu, Camelia [1 ,2 ,3 ]
Raffi, Francois [4 ]
Spire, Bruno [1 ,2 ,3 ]
Hardel, Lucile [5 ]
Michelet, Christian [6 ]
Cheneau, Christine [7 ]
Le Moing, Vincent [8 ]
Leport, Catherine [9 ,10 ]
Carrieri, Maria Patrizia [1 ,2 ,3 ]
机构
[1] INSERM, SESSTIM UMR912, Marseille, France
[2] Aix Marseille Univ, IRD, UMR S912, Marseille, France
[3] Observ Reg Sante Prov Alpes Cote dAzur, ORS PACA, Marseille, France
[4] CMIT, Paris, France
[5] Univ Bordeaux Segalen, ISPED, INSERM, U897, Bordeaux, France
[6] CHU Rennes, Rennes, France
[7] CHRU Strasbourg, Hop Civil CISIH, Strasbourg, France
[8] Univ Montpellier I, IRD, CHU Montpellier, Service Malad Infect & Trop,UMI TransVIHMI 233, Montpellier, France
[9] Univ Paris Diderot, Paris, France
[10] INSERM, IAME, UMR 1137, Paris, France
关键词
LEVEL SOCIOECONOMIC-STATUS; LIVER-RELATED MORTALITY; DISEASE PROGRESSION; GENERAL-POPULATION; ALL-CAUSE; EDUCATIONAL INEQUALITIES; DEPRESSIVE SYMPTOMS; MULTICENTER COHORT; TERM MORTALITY; DRUG-USERS;
D O I
10.3851/IMP2960
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Although the role of clinical/biological factors associated with mortality has already been explored in HIV-infected patients on antiretroviral therapy (ART), to date little attention has been given to the potential role of social vulnerability. This study aimed to construct an appropriate measure of social vulnerability and to evaluate whether this measure is predictive of increased mortality risk in ART-treated patients followed up in the ANRS CO8 APROCO-COPILOTE cohort. Methods: The cohort enrolled 1,281 patients initiating a protease inhibitor-based regimen in 1997-1999. Clinical/laboratory data were collected every 4 months. Self-administered questionnaires collected psycho-social/behavioural characteristics at enrolment (month [M] 0), M4 and every 8-12 months thereafter. A multiple correspondence analysis using education, employment and housing indicators helped construct a composite indicator measuring social vulnerability. The outcome studied was all-cause deaths occurring after M4. The relationship between social vulnerability and mortality, after adjustment for other predictors, was studied using a shared-frailty Cox model, taking into account informative study dropout. Results: Over a median (IQR) follow-up of 7.9 (3.0-11.2) years, 121 deaths occurred among 1,057 eligible patients, corresponding to a mortality rate (95% CI) of 1.64 (1.37, 1.96)/100 person-years. Leading causes of death were non-AIDS defining cancers (n=26), AIDS (n=23) and cardiovascular diseases (n=12). Social vulnerability (HR [95% CI] =1.2 [1.0, 1.5]) was associated with increased mortality risk, after adjustment for other known behavioural and bio-medical predictors. Conclusions: Social vulnerability remains a major mortality predictor in ART-treated patients. A real need exists for innovative interventions targeting individuals cumulating several sources of social vulnerability, to ensure that social inequalities do not continue to lead to higher mortality.
引用
收藏
页码:763 / 772
页数:10
相关论文
共 60 条
[1]  
[Anonymous], 2011, Stata statistical software: Release 12
[2]   Late presentation of HIV infection: a consensus definition [J].
Antinori, A. ;
Coenen, T. ;
Costagiola, D. ;
Dedes, N. ;
Ellefson, M. ;
Gatell, J. ;
Girardi, E. ;
Johnson, M. ;
Kirk, O. ;
Lundgren, J. ;
Mocroft, A. ;
Monforte, A. d'Arminio ;
Phillips, A. ;
Raben, D. ;
Rockstroh, J. K. ;
Sabin, C. ;
Sonnerborg, A. ;
de Wolf, F. .
HIV MEDICINE, 2011, 12 (01) :61-64
[3]  
Arno PS, 1996, J HEALTH CARE POOR U, V7, P36
[4]   Antiretroviral therapy of late presenters with advanced HIV disease [J].
Battegay, Manuel ;
Fehr, Jan ;
Flueckiger, Ursula ;
Elzi, Luigia .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (01) :41-44
[5]   Tobacco addiction and HIV infection: Toward the implementation of cessation programs. ANRS CO3 Aquitaine Cohort [J].
Benard, Antoine ;
Bonnet, Fabrice ;
Tessier, Jean-Francois ;
Fossoux, Helene ;
Dupon, Michel ;
Mercie, Patrick ;
Ragnaud, Jean-Marie ;
Viallard, Jean-Francois ;
Dabis, Francois ;
Chene, Genevieve .
AIDS PATIENT CARE AND STDS, 2007, 21 (07) :458-468
[6]   ABC OF ALCOHOL - HELP - REFERRAL [J].
BISSELL, D ;
PATON, A ;
RITSON, B .
BRITISH MEDICAL JOURNAL, 1982, 284 (6314) :495-497
[7]   Nonadherence among HIV-Infected injecting drug users: The impact of social instability [J].
Bouhnik, AD ;
Chesney, M ;
Carrieri, P ;
Gallais, H ;
Moreau, J ;
Moatti, JP ;
Obadia, Y ;
Spire, B .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 :S149-S153
[8]   Self-reported side-effects of anti-retroviral treatment among IDUs: A 7-year longitudinal study (APROCO-COPILOTE COHORT ANRS CO-8) [J].
Carrieri, Maria Patrizia ;
Villes, Virginie ;
Raffi, Francois ;
Protopopescu, Camelia ;
Preau, Marie ;
Salmon, Dominique ;
Taieb, Audrey ;
Lang, Jean-Marie ;
Verdon, Renaud ;
Chene, Genevieve ;
Spire, Bruno .
INTERNATIONAL JOURNAL OF DRUG POLICY, 2007, 18 (04) :288-295
[9]   Low Alcohol Consumption as a Predictor of Higher CD4+Cell Count in HIV-Treated Patients: A French Paradox or a Proxy of Healthy Behaviors? The ANRS APROCO-COPILOTE CO-08 Cohort [J].
Carrieri, Maria Patrizia ;
Protopopescu, Camelia ;
Raffi, Francois ;
March, Laura ;
Reboud, Philippe ;
Spire, Bruno ;
Leport, Catherine .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 65 (04) :E148-E150
[10]  
CDC, 1992, MMWR RECOMM REP